Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive Kearon

Showing results (51-60 of 152) with videos related to

Pageof 16
Sort By:
Chest|September 24, 2004
Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyMark N Levine, Gary Raskob, Rebecca J Beyth, et al.
Thrombosis Research|May 14, 2018
Age-adjusted versus clinical probability-adjusted D-dimer to exclude pulmonary embolismSarah Takach Lapner, Scott M Stevens, Scott C Woller, et al.
Thrombosis and Haemostasis|August 4, 2017
Comparison of clinical probability-adjusted D-dimer and age-adjusted D-dimer interpretation to exclude venous thromboembolismSarah Takach Lapner, Jim A Julian, Lori-Ann Linkins, et al.
Journal of Thrombosis and Haemostasis : JTH|December 24, 2019
Clinical pre-test probability adjusted versus age-adjusted D-dimer interpretation strategy for DVT diagnosis: A diagnostic individual patient data meta-analysisSameer Parpia, Sarah Takach Lapner, Roger Schutgens, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|February 6, 2021
Performance of two clinical scales to assess quality of life in patients with post-thrombotic syndromeAngela Lee, Chu-Shu Gu, Suresh Vedantham, et al.
Chest|July 24, 2008
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Clive Kearon, Susan R Kahn, Giancarlo Agnelli, et al.
BMJ (Clinical Research Ed.)|May 26, 2011
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trialsFlorent Boutitie, Laurent Pinede, Sam Schulman, et al.
Annals of Internal Medicine|February 7, 2007
Brief communication: Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarinMartin J O'Donnell, Clive Kearon, Judy Johnson, et al.
Archives of Internal Medicine|October 27, 2010
Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic reviewAlfonso Iorio, Clive Kearon, Esmeralda Filippucci, et al.
Journal of the American Geriatrics Society|February 4, 2020
Clinical Predictors of Intracranial Bleeding in Older Adults Who Have Fallen: A Cohort StudyKerstin de Wit, Sameer Parpia, Catherine Varner, et al.
Pageof 16

Showing results (51-60 of 152) with videos related to

Sort By:
Pageof 16
Chest|September 24, 2004
Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyMark N Levine, Gary Raskob, Rebecca J Beyth, et al.
Thrombosis Research|May 14, 2018
Age-adjusted versus clinical probability-adjusted D-dimer to exclude pulmonary embolismSarah Takach Lapner, Scott M Stevens, Scott C Woller, et al.
Thrombosis and Haemostasis|August 4, 2017
Comparison of clinical probability-adjusted D-dimer and age-adjusted D-dimer interpretation to exclude venous thromboembolismSarah Takach Lapner, Jim A Julian, Lori-Ann Linkins, et al.
Journal of Thrombosis and Haemostasis : JTH|December 24, 2019
Clinical pre-test probability adjusted versus age-adjusted D-dimer interpretation strategy for DVT diagnosis: A diagnostic individual patient data meta-analysisSameer Parpia, Sarah Takach Lapner, Roger Schutgens, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|February 6, 2021
Performance of two clinical scales to assess quality of life in patients with post-thrombotic syndromeAngela Lee, Chu-Shu Gu, Suresh Vedantham, et al.
Chest|July 24, 2008
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Clive Kearon, Susan R Kahn, Giancarlo Agnelli, et al.
BMJ (Clinical Research Ed.)|May 26, 2011
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trialsFlorent Boutitie, Laurent Pinede, Sam Schulman, et al.
Annals of Internal Medicine|February 7, 2007
Brief communication: Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarinMartin J O'Donnell, Clive Kearon, Judy Johnson, et al.
Archives of Internal Medicine|October 27, 2010
Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic reviewAlfonso Iorio, Clive Kearon, Esmeralda Filippucci, et al.
Journal of the American Geriatrics Society|February 4, 2020
Clinical Predictors of Intracranial Bleeding in Older Adults Who Have Fallen: A Cohort StudyKerstin de Wit, Sameer Parpia, Catherine Varner, et al.
Pageof 16